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Sfactor for MACE (OR¼2.4; p¼0.04), and death (OR¼6.8; p¼0.001). Upon multi-
variate logistic regression adjusting for CKD, DEB/DES length, and focal ISR, DEB
was not associated with MACE (OR¼0.9; p¼0.71) or death (OR¼1.7; p¼0.44).
Conclusions: Chronic kidney disease is an independent predictor of adverse outcomes
following percutaneous treatment of ISR. When adjusted for confounders, DEB and
DES are associated with similar outcomes in this setting.
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Background: PCI procedure of RCA ostium stenosis is still a challenging issue due to
high stent restenosis rate, possibly due to mechanical stress. However, mechanisms of
restenosis following cobalt-chromium everolimus-eluting stent (EES) or stainless steel
biolimus-eluting stent (BES) implantation have not been well clariﬁed.
Methods: Sixty-fourRCAostium restenosis cases after 2ndgenerationDES (40EESand
24 BES) were retrospectively analyzed. Serial (post initial stent and follow-up as revas-
cularization) angiographic and IVUS evaluation were performed. In quantitative angio-
graphic analysis (QCA), incidence of stent fracture (deﬁned as complete separation of the
stent segments and/or the absence of a stent strut on magniﬁed ﬂuoroscopic image), and
partial (only one of the inner or outer struts was separated) and complete (both the inner
and outer struts were disconnected) fracture type were evaluated. In IVUS, serial changes
ofminimum lumen and stent area (SA), and degree of stent recoil atminimum lumen area,
deﬁned as (follow-up SA - baseline SA / baseline SA*100), were also measured.
Results: Average follow-up phase was 1410-months. Angiographic and IVUS
morphometric parameters were similar in both groups at baseline. Signiﬁcant lumen
narrowingwas observed from baseline to follow-up in both groups (10.24.6 to 2.52.0,
10.75.4 to 2.42.3 mm2 in minimum lumen area, EES vs. BES, p<0.01 from baseline
to follow-up for all). Stent fracturewasmore frequently observed inBES than EES (85 vs.
8%, p<0.01). In addition, complete fracturewas highly observed inBES (29%) compared
to EES (2%, p<0.05). In contrast, signiﬁcant stent recoil was observed in EES only
(11.85.7 to 9.05.4 mm2, p<0.01 from baseline to follow-up for EES, 11.64.8 to
11.33.4 mm2, p¼ns for BES, and degree of stent recoil was signiﬁcantly larger in EES
than BES (23.8 vs. 2.6%, p<0.05). Additionally, there was only 1 BES and no EES case
that both stent fracture and signiﬁcant recoil, resulting in stent restenosis, was observed.
Conclusions: Stent fracture appears to be the major cause of RCA ostium restenosis
after stainless steel BES, whereas stent recoil seem to be associated with restenosis
after cobalt-chromium EES.
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Background: Stent fracture (SF) is one of the complications after percutaneous
coronary intervention (PCI), although it is not often. To date many data on ﬁrst
generation drug-eluting stent (DES) fracture were published. However study on
second generation DES fracture is rare. The aim of this study was to assess the
predictors of second generation DES fracture.
Methods: From March 2010 to August 2012, a total of 1032 patients with 1283 lesions
who underwent successful implantation with second generation DES at Inje University
HaeundaePaikHospitalwere followed prospectively.Among them, 369 patients (35.7%)
with 476 (37.1%) lesions who underwent follow-up coronary angiography (CAG) 6 to 12
months after initial procedure, irrespective of clinical symptoms, were performed.
Results: SF was identiﬁed in 45 of 1032 patients (4.36%) and 51 of 1283 lesions
(3.82%). The patients were divided into SF group and non-SF group. The most
prevalent vessel of SF was the left anterior descending artery (24 lesions, 47.1%),
followed by the right coronary artery (16 lesions, 31.4%). Most lesions were classiﬁed
as type B2 (15 lesions, 29.4%) or type C (22 lesions, 43.2%). All implanted stents
were the second generation DES such as everolimus-eluting stents (17 stents, 33.3%),
zotarolimus-eluting stents (12 stents, 23.5%) and biolimus-eluting stents (10 stents,
19.7%). Compared with non-SF group, SF group was more likely to have stent
overlap (52.4% vs. 22.4%; p<0.001) and peri-procedural myocardial infarction
(32.6% vs. 12.1%; p<0.001). On multivariate logistic regression analysis, stent
overlap (odds ratio 3.45, 95% conﬁdence interval 1.66-7.17, p<0.001), Biolimus-
eluting stents (odds ratio 6.17, 95% conﬁdence interval 2.19, p<0.001), stent length
(odds ratio 1.07, 95% conﬁdence interval 1.02-1.13, p¼0.009), and peri-procedural
MI (odds ratio 3.14, 95% conﬁdence interval 1.36-7.23, p ¼0.007), were identiﬁed as
independent predictors for fracture of second generation stent.
Conclusions: The incidence of stent fracture in the second generation DES was
3.82%. The biolimus-eluting stent, overlapping stent, peri-procedural MI, and long
stent length are signiﬁcant determinants of stent fracture in the second generation.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrTCT-453
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Background: Although in-stent restenosis (ISR) after drug-eluting stent (DES) is
perceived to be a benign phenomenon, some patients with ISR showed clinical presen-
tation of acute coronary syndrome (ACS). We sought to identify parameters inﬂuencing
the likelihood of restenosis with clinical presentation of ACS after DES implantation.
Methods: Stented patients (n¼3,817) with DESs were retrospectively reviewed for
inclusion in the study from theKoreaUniversity PCIDatabase Registry. From this database,
age and sex-matched 302 patients (7.9%) with ISR were assigned to either the Stable ISR
group (n¼156) or the ACS ISR group (n¼146). Predictors of coronary restenosis with
clinical presentation of ACS were identiﬁed with Cox regression analyses.
Results: The rate of risk factors such smoking, hypertension, and diabetes were similar
between the 2 groups; moreover, the use of medications at baseline did not differ
signiﬁcantly between the 2 groups. More patients in the ACS ISR group showed two
vessel diseases (n¼70 [47.9%] vs. n¼44 [28.2%], P¼0.028, respectively). No signiﬁ-
cant differences in ISR pattern were noted between the 2 groups during the follow-up
angiogram. Follow-up MMP-2 level was signiﬁcantly higher in the ACS ISR group
when compared to the Stable ISRgroup (66,639+/-12,519 vs. 57,386+/-2,423, P¼0.011,
respectively). Age (Hazard ratio [HR], 1.13; 95% conﬁdence interval [CI], 1.02 to 1.26;
P¼0.024), diabetes (HR, 6.80; 95% CI, 1.16 to 39.9; P¼0.034), the use of aspirin (HR,
0.005; 95% CI, 0.001 to 0.760; P¼0.039), clopidogrel (HR, 0.010; 95% CI, 0.001 to
0.162; P¼0.001), ACE inhibitor (HR, 0.210; 95%CI, 0.003 to 0.515; P<0.001), the use
ofﬁrst generationDES (HR, 1.130; 95%CI, 1.030 to 1.260; P¼0.001), andMMP-2 level
(HR, 1.120; 95% CI, 1.001 to 1.190; P¼0.004) during follow-up were signiﬁcant
predictors of ISR with clinical presentation of ACS during the 3-year follow-up.
Conclusions: In the era of DES, older age, diabetes, the use of ﬁrst generation DES,
and increased MMP-2 levels were signiﬁcant predictors of ISR with clinical presen-
tation of ACS. In contrast, the use of aspirin, clopidogrel, high-dose statin, and ACE
inhibitor prevented ISR with clinical presentation of ACS.
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Background: Stent fracture (SF) after drug-eluting stent implantation has recently
became an important concern. However, the incidence and clinical impact of SF after
the Nobori biolimus-eluting stent (BES) remains unclear.
Methods: A total of 1031 patients with 1407 lesions undergoing BES implantation
and follow-up angiography 6 to 9 months after index procedure were analyzed. SF
was deﬁned as complete or partial separation of the stent, as assessed by plain ﬂuo-
roscopy, intravascular ultrasound, or optical coherence tomography during follow-up.
We assessed the rate of SF and major adverse cardiac events (MACE), deﬁned as
cardiac death, myocardial infarction, stent thrombosis, and clinically driven target
lesion revascularization (TLR) within 9 months.
Results: SF was observed in 58 of 1407 lesions (4.1%) and 57 of 1031 patients (5.5%).
Lesions with hinge motion (odd ratio [OR], 6.15; 95% conﬁdence interval [CI], 3.40-
11.46; p<0.001), tortuosity (OR, 3.12; 95% CI, 1.46-7.31; p¼0.003), or overlapping
stents (OR, 2.66; 95% CI, 1.23-5.81; p¼0.013) were independent predictors of SF. The
MACE rate within 9months were signiﬁcantly higher in the SF group than in the non-SF
group (28.1% vs. 4.6%, p<0.001). The rate of TLR was signiﬁcantly higher in the SF
group than in the non-SF group (28.0% vs. 4.1%, p<0.001), whereas the rate of
myocardial infarction and stent thrombosis were not different between the 2 groups
(1.8% vs. 1.0%, p¼0.61; 1.8% vs. 0.9%, p¼0.53, respectively).acts/POSTER/In-stent Restenosis and Stent Thrombosis B139
